Your browser doesn't support javascript.
loading
Molybdenum blue mediated photothermal immunoassay for CEA detection based on Ag4P2O7@Ag nanocomposites.
Wen, Yanfei; Yuan, Yuan; Zhang, Bing; Lin, Jianying; Zhao, Zhihuan; Li, Jing; Cheng, Yan.
  • Wen Y; College of Biomedical Engineering, Taiyuan University of Technology, Taiyuan, 030024, China.
  • Yuan Y; College of Biomedical Engineering, Taiyuan University of Technology, Taiyuan, 030024, China.
  • Zhang B; College of Biomedical Engineering, Taiyuan University of Technology, Taiyuan, 030024, China. Electronic address: zhangbing01@tyut.edu.cn.
  • Lin J; College of Biomedical Engineering, Taiyuan University of Technology, Taiyuan, 030024, China.
  • Zhao Z; College of Biomedical Engineering, Taiyuan University of Technology, Taiyuan, 030024, China.
  • Li J; College of Biomedical Engineering, Taiyuan University of Technology, Taiyuan, 030024, China.
  • Cheng Y; College of Medical Imaging, Shanxi Medical University, Taiyuan, 030001, China.
Talanta ; 249: 123665, 2022 Nov 01.
Article en En | MEDLINE | ID: mdl-35691125
ABSTRACT
A photothermal immunoassay was built for tumor marker detection based on Ag4P2O7@Ag nanocomposites. Ag4P2O7@Ag nanomaterials were synthesized by precipitation-photoreduction reaction, and characterized by transmission electron microscope (TEM), scanning electron microscopy (SEM), atomic force microscopy (AFM), X-ray photoelectron spectra (XPS) and X-ray powder diffraction (XRD). Come about PO43- derived from Ag4P2O7@Ag under acidic conditions react with ammonium molybdate in the action of reductant generating molybdenum blue. The photothermal change is due to molybdenum blue solution depending on the concentration of carcinoembryonic antigen (CEA) in immunoassay. Under optimal conditions, there is a linear relation between ΔT and CEA concentration in the range of 1 pg mL-1-40 ng mL-1 with the detection limit of 0.33 pg mL-1. Meanwhile, the developed photothermal immunoassay displays preferable selectivity, repeatability, and stability.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Antígeno Carcinoembrionario / Nanocompuestos Tipo de estudio: Diagnostic_studies Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Antígeno Carcinoembrionario / Nanocompuestos Tipo de estudio: Diagnostic_studies Idioma: En Año: 2022 Tipo del documento: Article